A clinical trial conducted in Tanzania and Mozambique and published in The Lancet Infectious Diseases concludes that expanding the use of molecular diagnostic tests on urine and stool samples, in addition to sputum, to detect tuberculosis in hospitalized people living with HIV does not improve early treatment initiation nor reduce short-term mortality.
The Verdict
ClassificationLikely Human
ConfidenceMedium confidence
Analyzedtext
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/abd7a71f-f6e8-493e-9185-0e10fb867bd9)